معرفی
Brian Cary is a Research Fellow in Drug Discovery Biology at Monash University, actively contributing to the structural and functional understanding of Class B1 G protein-coupled receptors (GPCRs), with implications for treating metabolic diseases such as type 2 diabetes and obesity.
His research focuses on the molecular mechanisms of GPCR activation, particularly how peptide agonists engage receptors like the GLP-1 and PTH receptors. Using advanced techniques such as cryo-electron microscopy (cryo-EM) and protein engineering, he investigates conformational dynamics, biased signaling, and cholesterol modulation in receptor function.
The recent publication trend highlights a strong emphasis on high-resolution structural insights into GPCR-ligand interactions, revealing mechanisms of signal transduction and allosteric regulation. His work bridges structural biology and pharmacology to inform rational drug design.
Brian Cary is a Chief Investigator and Primary Chief Investigator on active research projects funded by the Australian Research Council, indicating leadership in his field. He collaborates extensively with leading scientists including Paul Sexton, Denise Wootten, and Arthur Christopoulos. His work contributes to global health goals, particularly in metabolic disease research.
